About CHEPLAPHARM
CHEPLAPHARM is a company based in Mesekenhagen (Germany) founded in 1998 by Kurt Teubner. The company has 840 employees as of December 31, 2021. CHEPLAPHARM offers products and services including Specialty Pharmaceutical Products. CHEPLAPHARM operates in a competitive market with competitors including AmerisourceBergen, WuXi AppTec, FundaMental Pharma, PHOENIX group and CeGaT, among others.
- Headquarter Mesekenhagen, Germany
- Employees 840 as on 31 Dec, 2021
- Founders Kurt Teubner
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cheplapharm Arzneimittel Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$547 M (USD), Debt – Convertible
Oct 25, 2022
-
Investors
HSBC
& 5 more
-
Employee Count
840
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CHEPLAPHARM
CHEPLAPHARM offers a comprehensive portfolio of products and services, including Specialty Pharmaceutical Products.
Acquired and developed branded drugs for global markets
People of CHEPLAPHARM
Unlock access to complete
Funding Insights of CHEPLAPHARM
Investors in CHEPLAPHARM
CHEPLAPHARM has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HSBC, Deutsche Bank and UniCredit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sovereign wealth is managed and private equity investments are facilitated.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A family office is operated across Nordic and European regions.
|
Locked | Locked | Locked |
Investor details for CHEPLAPHARM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CHEPLAPHARM
Investment portfolio details for CHEPLAPHARM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CHEPLAPHARM
Detailed financials for CHEPLAPHARM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cheplapharm Comparisons
Peer comparison for CHEPLAPHARM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CHEPLAPHARM
CHEPLAPHARM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, WuXi AppTec, FundaMental Pharma, PHOENIX group and CeGaT, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Provider of drug development & research services for peptides & gene therapy, and neurological diseases
|
|
| Locked | Locked | Locked |
Leading European provider of pharmaceutical wholesale, retail, and supply chain services.
|
|
| Locked | Locked | Locked |
Provider of drug research and development services to develop genetic causes of rare diseases
|
Detailed competitors of CHEPLAPHARM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cheplapharm
Complete news archive for CHEPLAPHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CHEPLAPHARM
CHEPLAPHARM was founded in 1998 and raised its 1st funding round 18 years after it was founded.
CHEPLAPHARM is headquartered in Mesekenhagen, Germany. It is registered at Mesekenhagen, Mecklenburg-vorpommern, Germany.
As of Dec 31, 2021, the latest employee count at CHEPLAPHARM is 840.
Cheplapharm was established in 1998 as a family-run pharmaceutical company headquartered in Mesekenhagen, Germany. Operations focus on the development, marketing, and distribution of branded products across various therapeutic areas. The portfolio has been expanded through strategic acquisitions and partnerships, supporting worldwide distribution. As a specialty pharmaceutical entity, investments are directed toward long-established brands in the sector.
CHEPLAPHARM's top competitors include AmerisourceBergen, WuXi AppTec and SCHOTT Pharma.
CHEPLAPHARM offers Specialty Pharmaceutical Products.
CHEPLAPHARM has 6 investors. Key investors include HSBC, Deutsche Bank, UniCredit, GIC, and Atlantic Park.